NCT06124768

Brief Summary

The study aims to compare the modified approach through ipsilateral deep calf venous access or contralateral femoral venous access with the traditional approach through ipsilateral popliteal venous access for iliofemoral deep venous thrombosis (DVT) with distal popliteal vein thrombosis, and determine whether it can achieve similar therapeutic effects as iliofemoral DVT without distal popliteal vein thrombosis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
17mo left

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Jan 2021Oct 2027

Study Start

First participant enrolled

January 1, 2021

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

November 6, 2023

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 9, 2023

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2027

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

5.8 years

First QC Date

November 6, 2023

Last Update Submit

February 23, 2026

Conditions

Keywords

Deep venous thrombosisPercutaneous mechanical thrombectomyPost-thrombotic syndrome

Outcome Measures

Primary Outcomes (1)

  • Incidence of post-thrombotic syndrome

    Incidence of post-thrombotic syndrome (PTS) evaluated by Villalta score

    24-month

Secondary Outcomes (6)

  • Rate of catheter-directed thrombolysis

    Immediately after interventional surgery

  • Total time of interventional surgery

    Immediately after interventional surgery

  • Total dosage of urokinase

    Immediately after interventional surgery

  • Patency rate of lower limb vein

    24-month

  • Incidence of post-thrombotic syndrome

    12-month

  • +1 more secondary outcomes

Other Outcomes (3)

  • Major bleeding rate

    24 months

  • Venous thromboembolism recurrence rate

    24 months

  • All-cause death rate

    24 months

Study Arms (3)

Iliofemoral DVT with distal popliteal vein thrombosis treated by PMT through the modified access

Anterograde venography shows patients with iliofemoral DVT with distal popliteal vein thrombosis. PMT is performed via ipsilateral distal calf venous access or contralateral femoral access.

Procedure: Percutaneous mechanical thrombectomy (PMT) by the modified approach

Iliofemoral DVT with distal popliteal vein thrombosis treated by PMT through the traditional access

Anterograde venography shows patients with iliofemoral DVT with distal popliteal vein thrombosis. PMT is performed via ipsilateral popliteal venous access.

Procedure: Percutaneous mechanical thrombectomy (PMT) by the traditional approach

Iliofemoral DVT without distal popliteal vein thrombosis treated by PMT

Anterograde venography shows patients with iliofemoral DVT without distal popliteal vein thrombosis. PMT is performed via any access, such as ipsilateral femoral venous access or ipsilateral popliteal venous access.

Procedure: Traditional approach

Interventions

The approach will be punctured from either the ipsilateral femoral vein or popliteal vein. A hydrophilic guide wire and a catheter will be used to pass through the thrombus antegrade to the inferior vena cava. Percutaneous mechanical thrombectomy (PMT) catheter will be used to clear the thrombus. After PMT treatment, residual thrombus will be reevaluated by ascending venography. Catheter-directed thrombolysis (CDT) will be conducted if there is residual thrombus. Percutaneous balloon angioplasty (PTA) and stenting will be conducted if there is \>50% stenosis of the diameter of the iliac vein.

Iliofemoral DVT without distal popliteal vein thrombosis treated by PMT

The modified approach includes the ipsilateral calf venous access and the contralateral femoral venous access. Through contralateral femoral venous access, a hydrophilic guide wire and a catheter will be crossover through the thrombus side to the distal calf vein. The ipsilateral calf venous access will be punctured under the guidance of ascending venography. A hydrophilic guide wire and a catheter will be used to pass through the thrombus antegrade to the inferior vena cava. Percutaneous mechanical thrombectomy (PMT) catheter will be used to clear the thrombus. After PMT treatment, residual thrombus will be reevaluated by ascending venography. Catheter-directed thrombolysis (CDT) will be conducted if there is residual thrombus. Percutaneous balloon angioplasty (PTA) and stenting will be conducted if there is \>50% stenosis of the diameter of the iliac vein.

Iliofemoral DVT with distal popliteal vein thrombosis treated by PMT through the modified access

The traditional approach will be punctured from the ipsilateral popliteal vein under ultrasound guidance. A hydrophilic guide wire and a catheter will be used to pass through the thrombus antegrade to the inferior vena cava. Percutaneous mechanical thrombectomy (PMT) catheter will be used to clear the thrombus. After PMT treatment, residual thrombus will be reevaluated by ascending venography. Catheter-directed thrombolysis (CDT) will be conducted if there is residual thrombus. Percutaneous balloon angioplasty (PTA) and stenting will be conducted if there is \>50% stenosis of the diameter of the iliac vein.

Iliofemoral DVT with distal popliteal vein thrombosis treated by PMT through the traditional access

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with acute lower limb deep venous thrombosis (DVT) treated by percutaneous mechanical thrombectomy (PMT). The symptoms of DVT should no more than 14 days.

You may qualify if:

  • Age between 18-85 years old;
  • Acute DVT occurred no more than 14 days since the onset of disease;
  • DVT treated by percutaneous mechanical thrombectomy
  • Informed consent signed by patients.

You may not qualify if:

  • Patients who are known to be allergic to heparin, low molecular weight heparin, or contrast agent;
  • Women during pregnancy and lactation;
  • Patients with other diseases that may cause difficulty in the study or significantly shorten the life expectancy of patients (\<6 months);
  • Patients who are unable or unwilling to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renji Hospital

Shanghai, Shanghai Municipality, 200127, China

RECRUITING

MeSH Terms

Conditions

Venous ThrombosisPostthrombotic Syndrome

Condition Hierarchy (Ancestors)

ThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular DiseasesVenous Insufficiency

Study Officials

  • Ni Qihong, M.D.

    Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2023

First Posted

November 9, 2023

Study Start

January 1, 2021

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

October 31, 2027

Last Updated

February 25, 2026

Record last verified: 2026-02

Locations